Glucocorticosteroids for primary sclerosing cholangitis (Q24246617)

primary sclerosing cholangitis

inferred from title

1 reference

2

0 references

author name string

Wendong Chen

series ordinal

1

0 references

publication date

19 July 2004

0 references

published in

Cochrane Database of Systematic Reviews

0 references

cites work

Reported methodologic quality and discrepancies between large and small randomized trials in meta-analyses

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004036.PUB2

Pericholangitis in chronic ulcerative colitis: primary sclerosing cholangitis of the small bile ducts?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004036.PUB2

Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004036.PUB2

7 January 2021

Morphologic features of chronic hepatitis associated with primary sclerosing cholangitis and chronic ulcerative colitis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004036.PUB2

7 January 2021

A pilot, double-blind, controlled 1-year trial of prednisolone treatment in primary biliary cirrhosis: hepatic improvement but greater bone loss

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004036.PUB2

7 January 2021

Dual association of HLA DR2 and DR3 with primary sclerosing cholangitis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004036.PUB2

7 January 2021

Sclerosing cholangitis: broad spectrum of radiographic features

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004036.PUB2

7 January 2021

HLA-DR and HLA-DQ are not markers for rapid disease progression in primary sclerosing cholangitis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004036.PUB2

7 January 2021

Comparison of the clinicopathologic features of primary sclerosing cholangitis and primary biliary cirrhosis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004036.PUB2

7 January 2021

Hepatobiliary carcinoma associated with primary sclerosing cholangitis and chronic ulcerative colitis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004036.PUB2

7 January 2021

Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses?

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004036.PUB2

7 January 2021

Chronic cholestatic diseases

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004036.PUB2

7 January 2021

Biliary lavage with corticosteroids in primary sclerosing cholangitis. A clinical, cholangiographic and bacteriological study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004036.PUB2

7 January 2021

Efficacy of ursodeoxycholic acid treatment and endoscopic dilation of major duct stenoses in primary sclerosing cholangitis. An 8-year prospective study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004036.PUB2

7 January 2021

Small-duct primary sclerosing cholangitis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004036.PUB2

7 January 2021

Recent advances in the management of primary sclerosing cholangitis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004036.PUB2

7 January 2021

Current concepts. Primary sclerosing cholangitis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004036.PUB2

7 January 2021

Primary sclerosing cholangitis: resect, dilate, or transplant?

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004036.PUB2

7 January 2021

Serum interferon gamma in primary biliary cirrhosis: effect of ursodeoxycholic acid and prednisone therapy alone and in combination

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004036.PUB2

7 January 2021

Budesonide or prednisone in combination with ursodeoxycholic acid in primary sclerosing cholangitis: a randomized double-blind pilot study. Belgian-Dutch PSC Study Group

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004036.PUB2

7 January 2021

Oral budesonide in the treatment of primary sclerosing cholangitis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004036.PUB2

7 January 2021

Clinical, biochemical, and histological studies of osteomalacia, osteoporosis, and parathyroid function in chronic liver disease

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004036.PUB2

7 January 2021